Latest News about LLY
Recent news which mentions LLY
Mounjaro Scores Yet Another Win: Why Eli Lilly Is Still a Buy
August 25, 2024
Tickers
LLY
From Motley Fool
If You Like Eli Lilly, Then You'll Love This Little-Known Specialty Manufacturing Stock
August 24, 2024
From Motley Fool
From Motley Fool
From Benzinga
From Motley Fool
Tickers
LLY
From Motley Fool
From Motley Fool
Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages
August 21, 2024
From Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
August 21, 2024
From Benzinga
Asia Mixed, European Markets Advance; Gold Stays Near All Time High While Dollar Gains - Global Markets Today While US Slept
August 21, 2024
From Benzinga
Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?
August 21, 2024
From Motley Fool
Wall Street Eases, Bonds Rises, US Dollar Falls To 8-Month Low: What's Driving Markets Tuesday?
August 20, 2024
From Benzinga
Fabrinet Posts Strong Earnings, Joins Amer Sports, Hawaiian Holdings And Other Big Stocks Moving Higher On Tuesday
August 20, 2024
From Benzinga
Eli Lilly's Famed Obesity/Diabetes Treatment Tirzepatide Shows Potential To Cut Risk Of Developing Diabetes, Sustained Weight Loss Over 3 Years
August 20, 2024
From Benzinga
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
August 19, 2024
From Benzinga
Walmart Wins Bargain Games
August 19, 2024
From Motley Fool
Telehealth Firm Hims & Hers Health Rides High On Demand for Copycat Weight Loss Drugs Amid Supply Shortages
August 19, 2024
From Benzinga
Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond
August 19, 2024
From Motley Fool
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
August 18, 2024
From Motley Fool
Tickers
LLY
From Motley Fool
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
August 18, 2024
From Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
August 17, 2024
From Motley Fool
3 Fantastic Growth Stocks to Buy in August
August 17, 2024
From Motley Fool
Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters
August 17, 2024
Tickers
LLY
From Motley Fool
Doctors Struggle to Secure Medicare Coverage for Heart Patients on Novo Nordisk's Wegovy
August 16, 2024
From Benzinga
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.